Cargando…
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
BACKGROUND: Type 2 diabetes mellitus (T2DM) is one of the most widely spread diseases, affecting around 90% of the patients with diabetes. Metabolomics has proven useful in diabetes research discovering new biomarkers to assist in therapeutical studies and elucidating pathways of interest. However,...
Autores principales: | Mora-Ortiz, Marina, Alcala-Diaz, Juan F., Rangel-Zuñiga, Oriol Alberto, Arenas-de Larriva, Antonio Pablo, Abollo-Jimenez, Fernando, Luque-Cordoba, Diego, Priego-Capote, Feliciano, Malagon, Maria M., Delgado-Lista, Javier, Ordovas, Jose M., Perez-Martinez, Pablo, Camargo, Antonio, Lopez-Miranda, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609192/ https://www.ncbi.nlm.nih.gov/pubmed/36289459 http://dx.doi.org/10.1186/s12916-022-02566-z |
Ejemplares similares
-
A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
por: Rangel-Zuñiga, Oriol Alberto, et al.
Publicado: (2020) -
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2023) -
A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study
por: Jiménez-Lucena, Rosa, et al.
Publicado: (2018) -
Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients with Coronary Heart Disease: From the CORDIOPREV Study
por: Hidalgo-Moyano, Cristina, et al.
Publicado: (2022) -
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023)